Cas no 930111-11-8 (4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine)

4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenylmethanamine is a versatile chemical intermediate featuring a pyrazole core linked to a phenylmethanamine moiety. Its structural design combines the stability of the 3,5-dimethylpyrazole group with the reactivity of the primary amine, making it valuable for pharmaceutical and agrochemical synthesis. The compound exhibits favorable selectivity in coupling reactions due to the steric and electronic effects of the dimethylpyrazole substituent. Its amine functionality allows for further derivatization, enabling applications in ligand design and bioactive molecule development. The compound's well-defined structure and purity ensure consistent performance in research and industrial processes. Suitable for controlled reactions, it serves as a key building block in heterocyclic chemistry.
4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine structure
930111-11-8 structure
Product Name:4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine
CAS No:930111-11-8
MF:C12H15N3
MW:201.267602205276
MDL:MFCD04971082
CID:877946
PubChem ID:16640534
Update Time:2025-10-28

4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine Chemical and Physical Properties

Names and Identifiers

    • [4-(3,5-dimethylpyrazol-1-yl)phenyl]methanamine
    • 1-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]methanamine
    • 4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzylamine
    • 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine
    • AS-9270
    • MFCD04971082
    • AKOS000218469
    • 1-(4-Aminomethylphenyl)-3,5-dimethylpyrazole
    • (4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
    • CHEBI:194734
    • 930111-11-8
    • [4-(3,5-dimethyl-1H-pyrazol-1-yl)phenyl]methanamine
    • DTXSID10586300
    • FT-0745008
    • EN300-229893
    • SCHEMBL2288170
    • BB 0220092
    • [4-(3,5-dimethyl-1H-pyrazol-1-yl)benzyl]amine
    • STK346959
    • DB-079461
    • 4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzylamine 97%
    • G22397
    • 1-[4-(3,5-DIMETHYLPYRAZOL-1-YL)PHENYL]METHANAMINE
    • MDL: MFCD04971082
    • Inchi: 1S/C12H15N3/c1-9-7-10(2)15(14-9)12-5-3-11(8-13)4-6-12/h3-7H,8,13H2,1-2H3
    • InChI Key: PARNNKGLJSIUFI-UHFFFAOYSA-N
    • SMILES: N1(C(C)=CC(C)=N1)C1C=CC(CN)=CC=1

Computed Properties

  • Exact Mass: 201.12700
  • Monoisotopic Mass: 201.126597491g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 15
  • Rotatable Bond Count: 2
  • Complexity: 199
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.5
  • Topological Polar Surface Area: 43.8?2

Experimental Properties

  • Density: 1.123
  • Boiling Point: 336.862°C at 760 mmHg
  • Flash Point: 157.529°C
  • Refractive Index: 1.6
  • PSA: 43.84000
  • LogP: 2.64810

4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine Security Information

  • Hazardous Material Identification: C

4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine Customs Data

  • HS CODE:2933199090
  • Customs Data:

    China Customs Code:

    2933199090

    Overview:

    2933199090. Other structurally non fused pyrazole ring compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Alichem
A049005237-5g
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%
5g
$1061.28 2023-08-31
Alichem
A049005237-10g
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%
10g
$1313.20 2023-08-31
Alichem
A049005237-25g
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%
25g
$2484.36 2023-08-31
Chemenu
CM331305-100mg
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%+
100mg
$292 2021-06-16
Chemenu
CM331305-250mg
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%+
250mg
$422 2021-06-16
Chemenu
CM331305-1g
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%+
1g
$571 2021-06-16
Chemenu
CM331305-5g
(4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)methanamine
930111-11-8 95%+
5g
$1055 2021-06-16
Apollo Scientific
OR14860-1g
4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzylamine
930111-11-8 tech
1g
£244.00 2024-05-26
abcr
AB223104-1 g
4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzylamine; 95%
930111-11-8
1g
€330.80 2023-02-05
abcr
AB223104-1g
4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzylamine, 95%; .
930111-11-8 95%
1g
€397.00 2025-04-15

4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine Related Literature

Additional information on 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine

Comprehensive Overview of 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine (CAS No. 930111-11-8)

4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine (CAS No. 930111-11-8) is a specialized organic compound that has garnered significant attention in the fields of medicinal chemistry, material science, and agrochemical research. This compound, characterized by its unique pyrazole and phenylmethanamine moieties, serves as a versatile intermediate in the synthesis of various biologically active molecules. Its molecular structure, which includes a 3,5-dimethyl-1H-pyrazole ring linked to a phenylmethanamine group, offers a robust platform for further chemical modifications, making it a valuable asset in drug discovery and development.

In recent years, the demand for 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine has surged due to its potential applications in the design of novel pharmaceuticals. Researchers are particularly interested in its role as a building block for kinase inhibitors, which are critical in the treatment of cancers and inflammatory diseases. The compound's ability to interact with specific protein targets has made it a focal point in structure-activity relationship (SAR) studies, where scientists aim to optimize its efficacy and selectivity. Additionally, its stability and solubility properties have been extensively studied to ensure compatibility with various formulation techniques.

Beyond pharmaceuticals, CAS No. 930111-11-8 has found utility in the development of advanced materials. Its aromatic and heterocyclic components contribute to the creation of polymers with enhanced thermal and mechanical properties. This has led to its incorporation in high-performance coatings, adhesives, and electronic materials. The compound's ability to form stable complexes with metals also opens doors for its use in catalysis and sensor technologies, addressing the growing need for sustainable and efficient industrial processes.

One of the most frequently asked questions about 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine revolves around its synthesis and scalability. The compound is typically prepared through multi-step organic reactions, including condensation and reduction steps, with careful attention to yield and purity. Advances in green chemistry have also prompted researchers to explore eco-friendly synthetic routes, minimizing waste and energy consumption. These efforts align with the broader industry trend toward sustainable and cost-effective production methods.

The safety profile of CAS No. 930111-11-8 is another area of interest for users. While the compound is not classified as hazardous under standard regulations, proper handling and storage protocols are essential to ensure workplace safety. Material safety data sheets (MSDS) provide detailed guidelines on its use, including recommendations for personal protective equipment (PPE) and first-aid measures. These precautions are particularly relevant for laboratories and manufacturing facilities that handle large quantities of the compound.

In the context of drug discovery, 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine has been explored as a precursor for the development of central nervous system (CNS) therapeutics. Its structural features allow for blood-brain barrier penetration, making it a candidate for treating neurological disorders such as Alzheimer's and Parkinson's diseases. The compound's potential to modulate neurotransmitter systems has also sparked interest in psychiatric applications, including the treatment of depression and anxiety disorders.

The agrochemical industry has likewise recognized the value of CAS No. 930111-11-8. Its derivatives have shown promise as active ingredients in pesticides and herbicides, offering targeted action against pests while minimizing environmental impact. This aligns with the global push for sustainable agriculture and reduced reliance on traditional chemical agents. Researchers are actively investigating its mode of action to optimize efficacy and reduce resistance development in target organisms.

For those seeking to purchase 4-(3,5-dimethyl-1H-pyrazol-1-yl)phenylmethanamine, it is crucial to source the compound from reputable suppliers who adhere to stringent quality control standards. Analytical techniques such as HPLC, NMR, and mass spectrometry are commonly employed to verify purity and identity. Buyers should also consider factors such as packaging, storage conditions, and regulatory compliance to ensure the material meets their specific requirements.

Looking ahead, the future of CAS No. 930111-11-8 appears bright, with ongoing research uncovering new applications and refining existing ones. Its versatility and adaptability make it a cornerstone in the development of next-generation therapeutics, materials, and agrochemicals. As the scientific community continues to explore its potential, this compound is poised to play a pivotal role in addressing some of the most pressing challenges in chemistry and beyond.

Recommended suppliers
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hunan Well Medicine Synthesis Technology Co., Ltd.
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.